GMAB Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: Genmab A/S

Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting

7 days ago - By: Zacks Investment Research - Mentions: JNJ ABBV

AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised

18 days ago - By: Benzinga

Why Is Genmab Stock Trading Lower On Monday?

18 days ago - By: Benzinga - Mentions: EXEL CCM CLLS ADXN ...

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

20 days ago - By: Genmab

Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer

a month ago - By: Zacks Investment Research - Mentions: AEG GFI SCSC DORM

New Strong Buy Stocks for October 3rd

a month ago - By: Brodsky & Smith LLC - Mentions: EA MRUS BRY CRC ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq - EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq - BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

a month ago - By: The Motley Fool

Why Genmab Stock Popped on Friday

a month ago - By: The Motley Fool

Why Genmab Stock Was Marching Higher Today

a month ago - By: Brodsky & Smith LLC - Mentions: EA MRUS BRY SMLR ...

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Electronic Arts Inc. (Nasdaq – EA), Merus N.V. (Nasdaq – MRUS), Berry Corporation (Nasdaq – BRY), Semler Scientific, Inc. (Nasdaq – SMLR)

a month ago - By: Investor's Business Daily - Mentions: PFE AAPL MRUS

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus

a month ago - By: Genmab A/S - Mentions: MRUS

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model

3 months ago - By: Zacks Investment Research - Mentions: ACAD

GMAB vs. ACAD: Which Stock Is the Better Value Option?

2 months ago - By: Genmab A/S

Genmab Announces Updated Results from Phase 2 EPCORE® NHL-6 Study Evaluating Epcoritamab Monotherapy in the Outpatient Setting in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

2 months ago - By: Yahoo Finance - Mentions: ABBV JNJ

Genmab A/S (GMAB)’s Epcoritamab Delivers 95% Response in Lymphoma

2 months ago - By: Yahoo Finance - Mentions: PFE ABBV

Genmab A/S (GMAB) Expands Tivdak and Epkinly Commercial Push Globally

2 months ago - By: Yahoo Finance - Mentions: ACAD

ACADIA Pharmaceuticals Inc. (ACAD) Nears Phase 3 Readout in Prader-Willi Syndrome Trial

2 months ago - By: Genmab A/S

Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC)

3 months ago - By: Yahoo Finance

William Blair Remains Bullish on Genmab A/S (GMAB)

3 months ago - By: Zacks Investment Research - Mentions: CRMD IOVA IMCR

IOVA Q2 Earnings Miss, Stock Down on EMA Filing Withdrawal for Amtagvi

3 months ago - By: Zacks Investment Research

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade

3 months ago - By: Genmab

Genmab Announces Phase 3 EPCORE® FL-1 Clinical Trial Met Dual Primary Endpoints in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL)

3 months ago - By: Zacks Investment Research - Mentions: PRGO CRMD IMCR

Perrigo Beats on Q2 Earnings & Sales, Stock Down on '25 Sales View Cut

3 months ago - By: Zacks Investment Research - Mentions: JAZZ CRMD IMCR

JAZZ Stock Down on Wider-Than-Expected Q2 Loss, '25 Sales View Cut

3 months ago - By: Zacks Investment Research - Mentions: SIRI VRTX CRSP IMCR

CRSP Stock Down on Huge Q2 Loss, Focus on Increasing Casgevy Adoption

3 months ago - By: Zacks Investment Research - Mentions: SNY BMRN IMCR

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

3 months ago - By: Zacks Investment Research - Mentions: SRPT ACAD

Sarepta to Report Q2 Earnings: What's in Store for the Stock?

3 months ago - By: Zacks Investment Research - Mentions: TECH CRMD AMRX

Bio-Techne Q4 Earnings Preview: What's in Store for the Stock?

4 months ago - By: Yahoo Finance - Mentions: GS

Truist Securities Hikes Genmab A/S (GMAB) Price Target Buoyed by Revenue Outlook

4 months ago - By: Yahoo Finance - Mentions: UBS NVS JNJ

UBS Maintains a Buy on Genmab (GMAB) With a DKK2,500 PT

4 months ago - By: Yahoo Finance - Mentions: RXRX UBS RLYB

GENMAB A/S -SP ADR (GMAB) Stock News